Cenkos upgraded its forecast for medical imaging technology provider IXICO (LON: IXI) following the interim figures, yet the share price fell by nearly 10%. That is because of caution about the next financial year when there is likely to be a return to loss.
IXICO continues to win additional contracts, although they will have more impact in the future.
Interim revenues fell from £4.9m to £3.9m. That was not a surprise because it was flagged that there would be a decline this year, which was exacerbated by the early closing of a study. Pre-tax profit fell from £635,000 to £201,000...
